Keyword: Horizon Discovery
Oxford Genetics has licensed CRISPR gene editing technology from ERS Genomics.
Horizon Discovery has struck a deal to evaluate cell line optimization technology developed by Amplycell.
Desktop Genetics, Horizon Discovery and Vectalys have teamed up to develop custom-made CRISPR lenti-gRNA libraries.
Just a few months after launching with a $55 million Series A round, Third Rock upstart Fulcrum Therapeutics has signed its first major partnership with the U.K.’s Horizon Discovery as they look to put CRISPR to use for rare, genetic diseases.